ATE307339T1 - Verwendung des vaskularen endothelialen wachstumsfaktors (vegf) - Google Patents
Verwendung des vaskularen endothelialen wachstumsfaktors (vegf)Info
- Publication number
- ATE307339T1 ATE307339T1 AT99959565T AT99959565T ATE307339T1 AT E307339 T1 ATE307339 T1 AT E307339T1 AT 99959565 T AT99959565 T AT 99959565T AT 99959565 T AT99959565 T AT 99959565T AT E307339 T1 ATE307339 T1 AT E307339T1
- Authority
- AT
- Austria
- Prior art keywords
- vegf
- growth factor
- vascular endothelial
- endothelial growth
- phosphorylation
- Prior art date
Links
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 title abstract 8
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title abstract 8
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title abstract 8
- 230000026731 phosphorylation Effects 0.000 abstract 4
- 238000006366 phosphorylation reaction Methods 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 102100028003 Catenin alpha-1 Human genes 0.000 abstract 1
- 101710106619 Catenin alpha-3 Proteins 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9827407.9A GB9827407D0 (en) | 1998-12-11 | 1998-12-11 | Methods |
| GBGB9908061.6A GB9908061D0 (en) | 1999-04-08 | 1999-04-08 | Methods |
| PCT/GB1999/004162 WO2000036421A1 (en) | 1998-12-11 | 1999-12-10 | Use of vascular endothelial growth factor (vegf) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE307339T1 true ATE307339T1 (de) | 2005-11-15 |
Family
ID=26314824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99959565T ATE307339T1 (de) | 1998-12-11 | 1999-12-10 | Verwendung des vaskularen endothelialen wachstumsfaktors (vegf) |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20020037544A1 (de) |
| EP (1) | EP1137946B1 (de) |
| JP (1) | JP2002532720A (de) |
| AT (1) | ATE307339T1 (de) |
| DE (1) | DE69927845D1 (de) |
| WO (1) | WO2000036421A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI428143B (zh) * | 2006-01-18 | 2014-03-01 | Gen Hospital Corp | 增加淋巴功能之方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5155031A (en) * | 1990-06-07 | 1992-10-13 | Posner Barry I | Use of pervanadate as an inhibitor of phosphotyrosine phosphatase |
| GB9323884D0 (en) * | 1993-11-19 | 1994-01-05 | Eisai London Res Lab Ltd | Physiological modulation |
| GB9423372D0 (en) * | 1994-11-18 | 1995-01-11 | Eisai London Res Lab Ltd | Proteins and their uses |
| GB9620390D0 (en) * | 1996-09-30 | 1996-11-13 | Eisai London Res Lab Ltd | Substances and their uses |
-
1999
- 1999-12-10 WO PCT/GB1999/004162 patent/WO2000036421A1/en not_active Ceased
- 1999-12-10 JP JP2000588609A patent/JP2002532720A/ja active Pending
- 1999-12-10 EP EP99959565A patent/EP1137946B1/de not_active Expired - Lifetime
- 1999-12-10 AT AT99959565T patent/ATE307339T1/de not_active IP Right Cessation
- 1999-12-10 DE DE69927845T patent/DE69927845D1/de not_active Expired - Lifetime
-
2001
- 2001-06-11 US US09/877,244 patent/US20020037544A1/en not_active Abandoned
-
2003
- 2003-01-23 US US10/349,111 patent/US20030134334A1/en not_active Abandoned
- 2003-01-23 US US10/349,074 patent/US20030129662A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000036421A8 (en) | 2000-12-21 |
| JP2002532720A (ja) | 2002-10-02 |
| WO2000036421A1 (en) | 2000-06-22 |
| EP1137946B1 (de) | 2005-10-19 |
| DE69927845D1 (de) | 2005-11-24 |
| EP1137946A1 (de) | 2001-10-04 |
| US20030129662A1 (en) | 2003-07-10 |
| US20020037544A1 (en) | 2002-03-28 |
| US20030134334A1 (en) | 2003-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60141950D1 (de) | Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung | |
| LTPA2014028I1 (lt) | Pakeistieji 3-cianochinolinai kaip proteintirozinkinazės inhibitoriai | |
| ATE115994T1 (de) | Quasi-azeotrope mischungen zur verwendung als kältemittel. | |
| DK162217C (da) | Chlorquinolinderivater, herbicid indeholdende disse chlorquinolinderivater og fremgangsmaade til bekaempelse af uoensket plantevaekst med dette herbicid | |
| ATE255575T1 (de) | Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren | |
| DK0526488T3 (da) | Benzylphosphonsyre-tyrosinkinaseinhibitorer | |
| EA200100315A1 (ru) | Простые тетрагидропиридовые эфиры | |
| TR199900781T2 (xx) | H�cre yap��ma inhibit�rleri | |
| EA199900381A1 (ru) | Арил(тио)эфиры галогенпиримидина в качестве пестицидов | |
| CA2382199A1 (en) | Hematology control and system for multi-parameter hematology measurements | |
| EA200100208A1 (ru) | Новая форма соли пантопразола | |
| DE60033918D1 (de) | Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung | |
| DE69431201D1 (de) | Verwendung von indolderivaten als 5ht1-agonisten | |
| PT1276763E (pt) | Proteinas anti-congelantes sua producao e utilizacao | |
| DE60107718T8 (de) | Konservierung von zellen | |
| WO2003021265A8 (en) | Genetic construct intracellular monitoring system | |
| DE69927845D1 (de) | Verwendung des vaskularen endothelialen wachstumsfaktors (vegf) | |
| DK1064018T3 (da) | Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktioner | |
| EA200100051A1 (ru) | Ингибиторы fkbp | |
| EA200200798A1 (ru) | Кальцилитические соединения | |
| TR200100013T2 (tr) | N-tert-butilhidroksilaminin yeni tuzları. | |
| TR200003713T2 (tr) | Homosistein ve C-reaktif proteinin seviyelerinin düşürülmesi. | |
| DE50106936D1 (de) | Lösung zur Konservierung menschlicher Leberzellen, konservierte Leberzelle, und ihre Verwendung | |
| ATE256661T1 (de) | Bispiperidine mit antithrombotischer wirkung | |
| DE68903268D1 (de) | Verwendung von folinsaeurederivaten als plaettchenaggregationshemmstoffe. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |